Within the current study, the role of Notch1R in macrophage differentiation was investigated as well as downstream effects in THP-1 monocytes cultured in "inflammation mimicry" media. Interference of Notch signaling was achieved using either the pharmaceutical inhibitor DAPT or Notch1R small interfering RNA (siRNA), and Notch1R expression, macrophage phenotypes, and anti-and proinflammatory cytokine expression were evaluated. Data presented show that Notch1R expression on M1 macrophages as well as M1 macrophage differentiation is significantly elevated during cellular stress (P Ͻ 0.05). However, under identical culture conditions, interference to Notch signaling via Notch1R inhibition mitigated these results as well as promoted M2 macrophage differentiation. Moreover, when subjected to cellular stress, macrophage secretion of proinflammatory cytokines was significantly heightened (P Ͻ 0.05). Importantly, Notch1R inhibition not only diminished proinflammatory cytokine secretion but also enhanced anti-inflammatory protein release (P Ͻ 0.05). Our data suggest that Notch1R plays a pivotal role in M1 macrophage differentiation and heightened inflammatory responses. Therefore, we conclude that inhibition of Notch1R and subsequent downstream signaling enhances monocyte to M2 polarized macrophage outcomes and promotes anti-inflammatory mediation during cellular stress. Notch 1; monocytes; macrophages; polarization; atherosclerosis THE STUDY OF MACROPHAGE POLARIZATION is emerging as a novel area of research that could yield new methods for the treatment of inflammatory diseases such as atherosclerosis. During an inflammatory response, monocytes migrate to the area of injury and differentiate into two types of macrophages known as M 1 and M 2 polarized macrophages based on diverse activation signals (2, 16) . Each category of macrophages has distinct properties that can either negatively or positively affect the inflammatory response and progression of the disease. M 1 macrophages are activated by various macrophage-activating factors including interferon (IFN)-␥, tumor necrosis factor (TNF)-␣, and bacterial lipopolysaccharide (LPS) (3, 19, 21) . They are characteristically proinflammatory, secreting various cytokines and toxic reactive oxygen intermediates including inducible nitric oxide synthase (iNOS), IL-6, TNF-␣, and MCP-1. Although M 1 macrophages are needed for normal host defense mechanisms, during diseased states they have the capability to enhance profligate inflammatory responses and exacerbate injury. On the other hand, M 2 macrophages, activated by unique cues including IL-4 and IL-13, are antiinflammatory and promote wound repair and healing, in part, through the secretion of IL-10, IL-1RA, and arginase 1 (14, 19, 24) . Based on the established properties of M 1 and M 2 macrophages, methods to direct differentiation and polarization of monocytes into M 2 macrophages offer new opportunities for the development of pharmaceutical therapies for the treatment of inflammatory diseases.
The Notch signaling pathway plays a fundamental role in cell-to-cell communication in a variety of tissues and organs throughout the body and is implicated in many genetic and acquired diseases and conditions (5, 13, 26, 34) . Specifically, the Notch pathway is associated with cell fate determination and differentiation, proliferation, and apoptosis, to name a few. The Notch pathway is initiated by ligand binding to the transmembrane Notch signaling receptor, which results in proteolytic cleavage of the Notch receptor. The intracellular domain then translocates to the nucleus where gene regulation is altered. There are four types of Notch receptors: Notch1R, Notch2R, Notch3R, and Notch4R, all of which have been shown to be expressed on either primary monocytes or macrophages (5, 12, 18, 31) . In fact, evidence provided suggests Notch signaling plays a critical role in monocytic cell fate determination and participates in macrophage modulation (11, 22) . Recently, studies showed that increased expression of Notch1R results in the progression of lung and vascular inflammation and can induce M 1 macrophage differentiation and proinflammatory cytokine expression (23, 25, 26) . Moreover, inhibition of the Notch 1 receptor by a ␥-secretase inhibitor, N-[N- (3,5- 
difluorophenacetyl)-l-alanyl]-S-phenylglycine t-bu-
tyl ester (DAPT), which works by inhibiting the cleavage of transmembrane proteins including Notch receptors, has been shown to reduce atherosclerosis in apolipoprotein E-deficient mice (1) . However, whether the mechanisms of inhibited atherosclerosis are mediated through monocyte-macrophage polarization regulation or another pathway altogether is completely unknown.
In the present study, we hypothesized that inhibition of Notch1R and subsequent Notch signaling would promote M 2 macrophage activation and diminish M 1 macrophage differentiation. Our data show that monocytes contain the Notch1R, and when these monocytes were treated with either DAPT or Notch1R small interfering RNA (siRNA), expression of Notch1R significantly decreased. Furthermore, our data demonstrate that following Notch1R inhibition, expression of proinflammatory markers iNOS, IL-6, TNF-␣, and MCP-1 were significantly decreased, whereas anti-inflammatory markers CD206, IL-10, IL-1RA, and arginase 1 were significantly increased. Our data suggest that activation of Notch1R results in proinflammatory M 1 macrophage differentiation and an increased inflammatory response. However, when Notch1R was inhibited by either a pharmacological inhibitor like DAPT or by siRNA technology, differentiation toward M 2 significantly increased along with anti-inflammatory markers, suggesting the significant role Notch1R plays in the areas of monocyte differentiation, macrophage polarization, and inflammation.
MATERIALS AND METHODS
THP-1 cell culture. THP-1 cells, a human monocytic cell line, were purchased from the American Type Culture Collection (ATCC, Manassas, VA). The cells were cultured in 25-cm 2 flasks with RPMI 1640 (ATCC) media that was supplemented with 10% fetal bovine serum and 0.05 mM ␤-mercaptoethanol. Media was changed every other day.
Apoptotic-conditioned media model. To induce stressed conditions, apoptotic-conditioned media (ACM) was used as we previously reported (28) . In brief, H9c2 cardiomyoblasts were plated for 24 h in 60-mm tissue culture dishes with 5 ϫ 10 5 cells in each plate. After 24 h, 400 M of H2O2 was added to each plate for 2 h. Following 2 h of treatment, the media was removed, filtered, and labeled as ACM. The ACM was stored in 15-ml conical tubes at 4°C for future use.
DAPT treatment. THP-1 monocytes were plated on 48-well plates with 20,000 cells seeded per well for 24 h. Cells were divided into the following groups: control (RPMI media), ACM (RPMI media ϩ 40% ACM), ACM ϩ DAPT (RPMI media ϩ 40% ACM ϩ 30 M DAPT), and control ϩ DAPT (RPMI media ϩ 30 M DAPT). Forty-eight hours posttreatment, cell smears were prepared for immunohistochemistry to identify macrophage differentiation based on cell surface markers, and supernatant was preserved for cytokine analysis.
Notch 1 receptor siRNA. Notch1R expression was knocked down in THP-1 monocytes using Notch 1 siRNA following manufacturer's instructions (No. sc-36095, Santa Cruz Biotechnology, Santa Cruz, CA). In brief, 1 ϫ 10 6 monocytes were placed into 1. TNF-␣ (No. ELH-TNFa), and MCP-1 (No. ELH-MCP1) were purchased from RayBiotech (Norcross, GA). Following treatments, cell culture supernatant was isolated and assays were performed according to manufacturer's instructions provided within each kit. Each color reaction was measured in a microtiter plate reader at 450 nm and was normalized to protein concentration. Data is presented as arbitrary units (AU).
Sodium dodecyl sulfate polyacrylamide gel electrophoresis and Western blot analysis. Western blot experiments were carried out as previously reported (27) . In brief, proteins were separated on an 8 -10% polyacrylamide gel and semidry transferred to a PVDF membrane. Membranes were blocked with 5% milk followed by incubation with primary antibodies [Notch 1, (1:1,000, No. 3268s, Cell Signaling, Danvers, MA), cleaved (activated) Notch 1 (C-Notch 1, 1:1,000, No. 41475, Cell Signaling), Hes-1 (1 g/ml, No. ab49170, Abcam), or ␤-actin (1:1,000, No. 4967L, Cell Signaling)] at appropriate concentrations for 1 h at room temperature or at 4°C overnight. Following primary antibody incubation, membranes were incubated with appropriate secondary antibodies for 1 h. Resulting bands were scanned, and intensities were determined using NIH ImageJ software. Data, relative to ␤-actin, are expressed as arbitrary units.
Statistical analysis. One-way analysis of variance (ANOVA) followed by Tukey's test was used for data analysis. All data are shown as means Ϯ SE with statistical significance given when P Ͻ 0.05. anti-iNOS (M 1 macrophages) or anti-CD206 (M 2 macrophages) shown in red (b, f, j, and n), DAPI shown in blue (c, g, k, and o), and merged images (d, h, l, and p) are depicted in Fig. 1, A and B. Quantitative data suggest that Notch1R is significantly upregulated on differentiated M 1 macrophages following exposure to ACM relative to control cells (P Ͻ 0.05, Fig. 1C ). However, Notch1R expressing M 1 macrophages were significantly reduced when additionally treated with DAPT (P Ͻ 0.05, Fig. 1C ). Of note, no statistical significance was obtained for Notch1R expression on M 1 differentiated macrophages between the control group and the DAPT-treated cells not cultured in ACM (Fig. 1C) . Assessment of Notch1R expression on polarized M 2 macrophages revealed no deviation in the number of receptors among any of the control or treatment groups (Fig. 1E) .
RESULTS

Notch 1 receptor expression and macrophage differentiation
The percentages of THP-1-differentiated M 1 and M 2 macrophages were also analyzed. Consistent with Notch1R expression, the percentage of M 1 macrophages was significantly elevated following ACM treatment compared with control, which was abrogated in the presence of DAPT (P Ͻ 0.05, Fig.  1D ). However, when not cultured in "inflammation mimicry" media, M 1 macrophage concentrations were unchanged between control and control ϩ DAPT groups (Fig. 1D) . Interestingly, M 2 macrophage concentrations were significantly elevated in the ACM ϩ DAPT group compared with the ACM group (P Ͻ 0.05), whereas no deviation in M 2 macrophage outcomes were noted between the control and control ϩ DAPT groups (Fig. 1F) .
Proinflammatory cytokine expression altered in THP-1 cells following DAPT treatment. Activated macrophages, whether M 1 or M 2 , have unique cytokine profiles. Previous data suggest M 1 macrophages secrete various proinflammatory cytokines including IL-6, MCP-1, and TNF-␣ (16). To this end, media from each group was removed following experimental design time parameters and used to assess secreted cytokine concentrations. ELISA revealed that THP-1 monocytes cultured in ACM, compared with controls, secreted significantly higher quantities of IL-6, MCP-1, and TNF-␣, which is consistent with the M 1 macrophage phenotype (P Ͻ 0.05, Fig. 2, A-C) . However, THP-1 cells exposed to ACM, additionally treated with DAPT, had significantly reduced proinflammatory cytokine concentrations relative to the ACM group (P Ͻ 0.05, Fig.  2, A-C) . Notably, when cultured in absence of ACM but with DAPT, IL-6, MCP-1, and TNF-␣ expression was unaffected relative to control cells (Fig. 2, A-C) . 
Treatment with DAPT increases anti-inflammatory cytokine secretion from THP-1 cells.
As we previously identified, treatment with DAPT yielded significantly higher concentrations of M 2 macrophages during inflammation mimicry using ACM. As such, levels of anti-inflammatory cytokines, which are characteristically secreted from M 2 macrophages, were assessed for all control and experimental groups. No significant deviation in IL-10 and IL-1RA expression was reported between control and ACM groups (Fig. 2, D and E) . However, secreted IL-10 and IL-1RA were significantly augmented following DAPT treatment during stressed conditions compared with the ACM group (P Ͻ 0.05, Fig. 2, D  and E) . Additionally, no significant differences in IL-10 and IL-1RA expression were noted between control and control ϩ DAPT groups, which is consistent with the lack of significant difference in M 2 macrophage yields previously noted in Fig.  1F (Fig. 2, D and E) .
Notch 1 signaling is augmented in THP-1 cells following treatment with DAPT.
To demonstrate that DAPT treatment inhibits Notch 1 signaling in THP-1 cells exposed to inflammation mimicry media, levels of Notch 1, activated Notch 1 (C-Notch 1) and Hes-1, and a downstream effector in the Notch 1 signaling cascade were evaluated. Levels of Notch 1 and activated Notch 1 were unaffected in THP-1 cells exposed to ACM compared with controls (Fig. 3A) . However, when treated with DAPT, whether exposed to ACM or not, levels of Notch 1 and C-Notch 1 were significantly decreased in THP-1 cells compared with ACM alone-treated cells (P Ͻ 0.05, Fig.  3A) . Additionally, levels of Hes-1 were significantly enhanced in the ACM group compared with the control group (P Ͻ 0.05, Fig. 3B ). Notably, following DAPT treatment in control and ACM-treated THP-1 cells, Hes-1 expression was significantly diminished relative to the ACM group (P Ͻ 0.05, Fig. 3B ).
siRNA knockdown of Notch1R augments M 1 and M 2 macrophage differentiation in THP-1 cells. Widely accepted, DAPT is a promiscuous ␥-secretase inhibitor with target substrates not limited to Notch alone. As proof of concept and to strengthen our findings obtained using DAPT, Notch 1 signaling was also knocked down using Notch1R siRNA. Alterations to Notch1R expression and M 1 /M 2 differentiation were evaluated in THP-1 monocytes following siRNA treatment. The number of M 1 macrophages expressing Notch1R was significantly enhanced in the ACM group compared with control cells, both of which were treated with scrambled siRNA (P Ͻ 0.05, Fig. 4A) . Notably, treatment of ACM-stressed THP-1 monocytes with Notch1R siRNA significantly blunted Notch1R expression on M 1 macrophages compared with the ACM group (P Ͻ 0.05, Fig. 4A ). However, siRNA treatment to cells not exposed to ACM had no differences in Notch1R expressing M 1 macrophage concentrations between the control and siRNA groups ( phage concentrations were not significantly altered between any of the control or treatment groups (P Ͻ 0.05, Fig. 4C ). However, the overall percentage of CD206-positive M 2 macrophages was significantly increased following Notch1R siRNA treatment (P Ͻ 0.05, Fig. 4D ). Proinflammatory cytokine expression decreases following Notch 1 knockdown in THP-1 cells. Although Notch1R siRNA significantly diminished Notch1R expressing M 1 macrophages, the downstream consequences of such actions on proinflammatory secretion remains obscure. To that end, levels of IL-6, MCP-1, and TNF-␣ were evaluated, and analyzed data suggest a significant increase in all three secreted proinflammatory cytokines from stressed, scrambled siRNA-treated THP-1 monocytes (P Ͻ 0.05, Fig. 5, A-C) . Importantly, treatment with Notch1R siRNA resulted in significantly reduced IL-6, MCP-1, and TNF-␣ expression in the ACM ϩ siRNA and siRNA groups relative to the ACM group (P Ͻ 0.05, Fig. 5,  A-C) . However, when cells were treated with Notch1R siRNA and not exposed to ACM, proinflammatory cytokine secretion was unaffected relative to the control group (Fig. 5, A-C) .
Expression of anti-inflammatory cytokines is augmented following Notch1R knockdown in THP-1 monocytes. Quantified IL-10 expression was significantly upregulated in the ACM ϩ siRNA group relative to the ACM group (P Ͻ 0.05, Fig. 5D ). However, IL-10 was significantly upregulated following siRNA Notch1R knockdown in THP-1 cells not exposed to ACM (P Ͻ 0.05, Fig. 5D ), mimicking data obtained in THP-1 cells treated with DAPT. Additionally, IL-1RA expression was significantly elevated following Notch1R siRNA in ACM-treated THP-1 cells compared with ACMtreated cells (P Ͻ 0.05), whereas no difference was noted between control and siRNA groups (Fig. 5E) .
Notch 1 signaling is decreased in THP-1 cells following siRNA knockdown of Notch1R. As with DAPT-treated THP-1 cells, levels of Notch 1, activated Notch 1, and Hes-1 were evaluated following siRNA knockdown of Notch1R to illustrate Notch 1 signaling interference. Data presented suggest Notch 1 and activated Notch 1 expressions were significantly downregulated following treatment with Notch1R siRNA compared with the ACM group (P Ͻ 0.05, Fig. 6A ). Additionally, levels of Hes-1, which were significantly elevated in the ACM group relative to the control group, were significantly diminished following Notch1R siRNA compared with the ACM group (P Ͻ 0.05, Fig. 6B ). Collectively, our data suggest that Notch1R interference via DAPT and siRNA hinders Notch 1 activation and downstream cascade signaling.
DISCUSSION
During an immune or inflammatory response, monocytes are the first cell type to migrate to the injury site. Upon arrival, monocytes undergo reprogramming, yielding two distinct phenotypes of proinflammatory and anti-inflammatory macrophages, M 1 and M 2 , respectively, which is consequent to intracellular signals and the cellular microenvironment (2, 16, 19) . M 1 "classically activated" macrophages yield various cytotoxic effectors including reactive oxygen/nitrogen intermediaries and inflammatory chemokines/cytokines. Recent studies have suggested an association between predominant M 1 macrophage differentiation and disease pathophysiologies in- cluding that of cancer, atherosclerosis, and prediabetic phenotypes (4, 8, 15, 32) . Conversely, activated M 2 macrophages, which circumscribe all nonclassically polarized macrophages, are implicated in salutary mediation of inflammation by promoting resolution, remodeling, and repair, in part, through secretion of prototypical cytokines including IL-10, IL-1RA, and arginase-1 (2, 19) . Studies are currently underway to exploit novel growth factors/small molecules, which dictate M 1 /M 2 differentiation outcomes for therapeutic applications (6, 28, 30, 35) . Notably, we recently published data identifying bone morphogenetic protein-7 (BMP-7) as a novel differentiating signal, which promotes enhanced M 2 macrophage yields from THP-1 monocytes during inflammation mimicry in vitro (28) . Although it has been suggested that the dynamic monocyte to macrophage differentiation paradigm is dictated by microenvironmental signals, the mechanisms, which mandate macrophage phenotypic plasticity, remain largely unknown. Within this context, the current study was undertaken to identify possible alternative intracellular signaling pathways, independent of BMP-7, which are involved in M 1 /M 2 differentiation.
Widely accepted, the Notch signaling cascade dictates cell fate determination and tissue homeostasis in both physiological and pathological conditions. Evidence provided suggests inactivation of the Notch pathway mitigates atherosclerosis and vasculitis and enhances wound healing, whereas stimulation of the signaling cascade promotes pulmonary and cardiac inflammation as well as contributes to neoplasia and metastasis (1, 10, 23, 25) . Although a correlation between Notch signaling and inflammation has been established, the exact mechanisms have yet to be elucidated. Importantly, recent evidence has been provided suggesting Notch signaling plays a critical role in fate determination during tumor-associated macrophage activation (34) . Specifically, following forced Notch signaling and LPS stimulation, the M 1 phenotypic outcomes were dramatically enhanced, whereas blockade of Notch signaling promoted M 2 polarization, even in the presence of LPS and TNF-␣ (34) . Taking into account the aforementioned studies, we hypothesized that the inflammatory response is propagated and heightened through activation of Notch1R, specifically, which in turn promotes M 1 macrophage differentiation.
THP-1 monocytes were cultured in a specialized apoptoticconditioned media, which has been previously reported, inducing inflammation mimicry conditions driving monocyte polarization and macrophage differentiation (28) . Cells were additionally treated with DAPT, a ␥-secretase inhibitor, which has been used in countless studies to drive Notch signaling interference (9, 20, 33) . To validate Notch signaling impedition, Western blot analysis was performed and our data shows that when treated with DAPT, a significant decrease in activated Notch 1 expression was achieved.
To determine whether or not Notch1R-activated signaling plays a critical role in macrophage differentiation outcomes, Notch1R expression was evaluated on M 1 and M 2 macrophages as well as concentrations of each macrophage subset. The current findings suggest that THP-1 monocytic cells, when cultured in inflammation mimicry media, significantly differentiate toward the M 1 , the phenotype with a dramatic increase in Notch1R expression, which is concurrent with Kitajewski et al. (23) who suggest Notch 1 signaling plays a monumental role in activated macrophage propagation. Importantly, the addition of DAPT, a Notch inhibitor, significantly reduced the expression of Notch1R on differentiated M 1 macrophages as well as decreased the overall M 1 macrophage concentration. Although no difference was observed in Notch1R expression on M 2 macrophages, as evidenced by colocalization of Notch1R and CD206, the number of M 2 macrophages was significantly upregulated following ACM exposure and DAPT treatment. Our data suggest that Notch signaling plays a role in dictating macrophage differentiation during inflammation mimicry with predominant proinflammatory M 1 macrophage phenotypic outcomes.
Concurrent with increased M 1 macrophage concentrations consequent to ACM exposure, proinflammatory cytokine (IL-6, MCP-1, and TNF-␣) secretion was significantly escalated. Our data are in corroboration with Hirata et el. (10) who suggest a correlation between elevated M 1 macrophage concentration in epicardial adipose tissue obtained from coronary arterial disease (CAD) patients and upregulated IL-6, MCP-1, and TNF-␣ expression. Of importance, inhibition of the Notch pathway via DAPT significantly ameliorated proinflammatory cytokine expression while enhancing secreted anti-inflammatory cell signaling molecules, IL-10 and IL-1RA. The decreased levels of proinflammatory cytokines and the increased anti-inflammatory cytokine expression-yielded post-Notch pathway inhibition correlates with blunted M 1 macrophage differentiation and amplified M 2 macrophage activation. Overall, data presented suggest that interference of Notch signaling, specifically Notch1R, inhibits classical activation of M 1 macrophages and drives monocytic differentiation yielding M 2 -polarized macrophages, which is supported by data obtained from the pro-and anti-inflammatory cytokine profiles.
␥-Secretases, including DAPT, are promiscuous enzymes, which target and cleave multiple substrates independent of Notch including LDL receptor-related protein (LRP), E-cadherin, and ErbB-4 (17, 29, 36) . In lieu of the nonspecific inhibition of Notch1R via DAPT, additional studies were carried out in which the Notch1R was knocked down using siRNA to authenticate our data previously collected using DAPT. Consistent with the findings obtained using THP-1 cells treated with DAPT, M 1 macrophage differentiation and Notch1R expression on M 1 macrophages were drastically quenched, whereas M 2 macrophage differentiation was enhanced in the ACM ϩ Notch1R siRNA group relative to the ACM group. Additionally, knockdown of Notch1R and subsequent signaling inhibited IL-6, MCP-1, and TNF-␣ secretion while promoting anti-inflammatory cytokine release including IL-10 and IL-1RA.
Although the goal of the current article was to identify independent signaling cascades driving M 1 /M 2 differentiation outcomes, we acknowledge that often there is cross talk between various cellular communication pathways. For instance, we previously published a correlation between exogenous BMP-7 application to THP-1 monocytes during stressed conditions and enhanced M 2 macrophage differentiation and antiinflammatory cytokine expression (28) . Independent of our study, an investigation (7) was published suggesting BMP-7 restricts branching of the prostate epithelium with mechanistic implications of Notch signaling repression. Such data combined with the current findings may suggest that BMP-7 promotes anti-inflammatory macrophage differentiation, in part, through depressed Notch 1 signaling. Although speculative, future studies are warranted to identify upstream and downstream mediators driving M 2 macrophage paradigm shifts via Notch signaling inhibition.
In conclusion, our presented data suggest that Notch1R plays a key role in macrophage differentiation during the inflammatory response by driving M 1 macrophage activation and subsequent proinflammatory cytokine release. Additionally, treatment of THP-1 monocytes with DAPT or Notchspecific siRNA and subsequent Notch signaling interference resulted in significantly decreased M 1 macrophage differentiation and Notch1R expression, enhanced M 2 macrophage activation, and upregulated anti-inflammatory cytokine secretion. Future studies are warranted to determine the extent, if any, Notch2R, Notch3R, or Notch4R activation plays in monocytic differentiation and macrophage polarization. However, data presented identify a novel target, Notch1R, which may be used for future therapeutic applications in proinflammatory diseases.
